Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prevalence of Cystic Fibrosis and Pattern of Lung Function Impairment in Adults Presenting With Bronchiectasis at a Tertiary Care Hospital in Resource Poor Country Bangladesh: A Cross-Sectional Study.

Health science reports·2026
Same author

Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies.

Communications medicine·2026
Same author

Severe Multisystem Thrombotic Phenotype Associated With Protein C Deficiency in A Young Woman: A Case Report.

Clinical case reports·2026
Same author

Association Between Generalized Anxiety Disorder (GAD) and Polycystic Ovary Syndrome (PCOS) Diagnosed University-Going Female Students in Bangladesh: A Cross-Sectional Study.

Health science reports·2026
Same author

Correlation Between Disease Severity and Chest Computed Tomography Findings in Coronavirus Disease 2019 Patients in a University Hospital of Bangladesh-An Observational Study.

Health science reports·2026
Same author

Retraction notice to "Dendritic cell-derived exosomes (Dex); Underlying the role of exosomes derived from diverse DC subtypes in cancer pathogenesis" [Pathol.-Res. Pract. 254 (2024) 155097].

Pathology, research and practice·2026

相关实验视频

Updated: Jul 8, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.4K

基于mRNA的HIV-1疫苗

Shamim Ahmed1, Alon Herschhorn1,2,3,4,5,6,7

  • 1Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Clinical microbiology reviews
|July 17, 2024
PubMed
概括

针对严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 取得成功的信使RNA (mRNA) 疫苗,目前正在针对人类免疫缺陷病毒1型 (HIV-1) 开发. 这些新的HIV-1 mRNA疫苗正在临床前和临床试验中,以克服免疫逃避挑战.

关键词:
艾滋病病毒-1 艾滋病病毒-1包裹中的葡萄糖蛋白质.在mRNA疫苗的使用中.

更多相关视频

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

7.8K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.5K

相关实验视频

Last Updated: Jul 8, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.4K
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

7.8K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.5K

科学领域:

  • 疫苗学 疫苗学 疫苗学
  • 病毒学 病毒学
  • 免疫学 免疫学 免疫学

背景情况:

  • 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) mRNA疫苗的成功刺激了人们对开发其他传染病的mRNA技术的兴趣.
  • 人类免疫缺陷病毒1型 (HIV-1) 由于其快速突变率和免疫规避策略,对疫苗开发提出了重大挑战.
  • 尽管进行了数十年的研究,但有效的HIV-1疫苗仍然难以捉摸.

研究的目的:

  • 审查目前开发基于mRNA的HIV-1疫苗的战略.
  • 讨论HIV-1 mRNA疫苗候选人的各种准方法.
  • 总结最近的发现和HIV-1 mRNA疫苗开发的未来前景.

主要方法:

  • 关于在动物模型中制造和测试基于mRNA的HIV-1疫苗的临床前研究的审查.
  • 对HIV-1 mRNA疫苗正在进行和计划进行的临床试验的分析.
  • 对mRNA疫苗的不同抗原向策略和输送系统的检查.

主要成果:

  • 已经开发了多种基于mRNA的HIV-1疫苗候选剂,并在各种动物模型中进行了测试.
  • 已启动早期临床试验,计划进行更多的临床试验,以评估这些疫苗的安全性和免疫性.
  • 优化mRNA疫苗的设计和交付对于克服HIV-1的免疫逃避机制至关重要.

结论:

  • mRNA疫苗技术有望开发一种有效的HIV-1疫苗.
  • 解决HIV-1复杂的免疫逃避策略对于疫苗的成功至关重要.
  • 持续的研究和临床评估对于推进HIV-1 mRNA疫苗开发至关重要.